Autologous dendritic cell vaccination (DCVAC/OvCa) added to standard of care therapy in three open-label randomized phase 2 studies in women with advanced stage ovarian cancer (OC).
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr TPS3134)Clinical use of dendritic cells for cancer therapy
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2014-06-01 / Lancet Oncol. 2014 Jun;15(7):e257-67Intratumoral vaccination with activated allogeneic dendritic cells in patients with newly diganosed metastatic renal cell carcinoma (mRCC).
/in Dendritic Cells, Hypernephroma, International Publications /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3085)Randomized phase II study with dendritic cell (DC) immunotherapy in patients with resected hepatic metastasis of colorectal carcinoma.
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr TPS3129)Combined chemoimmunotherapy of castrate-resistant prostate cancer with dendritic-cell based vaccine DCVAC/Pca.
/in Dendritic Cells, International Publications, Prostate Cancer /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3095)Association of increased progression-free survival in primary glioblastomas with lymphopenia at baseline and activation of NK and NKT cells after dendritic cell immunotherapy.
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-05-31 / J Clin Oncol 32:5s, 2014 (suppl; abstr 2087)Dendritic cell vaccination in malignant pleural mesothelioma: A phase I/II study.
/in Dendritic Cells, International Publications /von 2014-05-31 / J Clin Oncol 32:5s, 2014 (suppl; abstr 7583)A feasibility and safety study of vaccination with poly-ICLC and peptide-pulsed dendritic cells in patients with metastatic, locally advanced unresectable, or recurrent pancreatic adenocarcinoma.
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2014-05-30 / J Clin Oncol 32, 2014 (suppl; abstr e15254)Dendritic cell immunotherapy for glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-05-21 / Expert Rev Anticancer Ther 2014 Jul;14(7):761-3IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de